Articles científics - VHIO: Enviaments recents
Ara mostrant els elements 41-60 de 468
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma
Adrenal gland diseases; Databases; Genetic variation
An accessible deep learning tool for voxel-wise classification of brain malignancies from perfusion MRI
Deep learning; Glioblastoma; Perfusion MRI
Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors
Dose escalation study; Human leukocyte antigen-G; Solid tumors
Hydrodynamic and Electrophoretic Properties of Trastuzumab/HER2 Extracellular Domain Complexes as Revealed by Experimental Techniques and Computational Simulations
Complexos Trastuzumab / HER2; Propietats hidrodinàmiques; Dinàmica molecular
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial
Machine learning; Tumor-immune microenvironment; Breast cancer
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
Càncer: Investigació genètica
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
Càncer de mama; Immunoteràpia; Danys en l’ADN
Implementation of an Educational Intervention for Gastric Cancer Awareness in the General Population in CELAC and Europe: A Strategy Proposed by the LEGACy Consortium
Gastric cancer; Gastric cancer risk factors; Gastro-esophageal cancer
Three-dimensional cell culture of chimeric antigen receptor T cells originated from peripheral blood mononuclear cells towards cellular therapies
3D cell culture; CAR T cells; Adoptive cell therapy
Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer
POLD1 mutations; Immune checkpoint inhibitors; Metastatic colorectal cancer
Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer
DNA damage response; PARP inhibition; Prostate cancer
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial
Molecular testing; Ovarian cancer
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
Glucocorticoid receptor; Neoplasm drug resistance; Ovarian neoplasms
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy
Differentiated thyroid cancer; Multikinase inhibitor; Progression-free survival
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer
Medullary thyroid cancer; Selpercatinib; Targeted therapy
Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals
Síndrome de Lynch; Panell de gens del càncer; Epimutació
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
Inhibidors de PARP; Càncer d’ovari avançat
The change of paradigm in the treatment of HER2-positive breast cancer with the development of new generation antibody-drug conjugates
Breast cancer; HER2-positive; New drugs
